SCHEMBL30833753

SCHEMBL30833753

CS(=O)(=O)N1CCCc2cccc([N+](=O)[O-])c21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.54
MEN1 O00255 5/20 0.54
NLRP3 Q96P20 1/20 0.52
ALDH1A1 P00352 5/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
HTT P42858 2/20 0.44
GAA P10253 1/20 0.42
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
AKR1C3 P42330 1/20 0.38
AKR1C1 Q04828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29190601 1.00 KMT2A (0.54) KMT2AMEN1NLRP3ALDH1A1CYP1A2
SCHEMBL26778543 0.92 ALDH1A1 (0.51) KMT2AMEN1NLRP3ALDH1A1CYP1A2
SCHEMBL14591325 0.78 ALOX12 (0.56) KMT2AMEN1ALDH1A1HTTKDM4E
SCHEMBL30871992 0.78 CYP1A2 (0.54) KMT2AMEN1ALDH1A1CYP1A2CYP2C9
SCHEMBL29190645 0.77 CES1 (0.45) KMT2AMEN1NLRP3ALDH1A1HTT
SCHEMBL30833729 0.77 CES1 (0.45) KMT2AMEN1NLRP3ALDH1A1HTT
SCHEMBL19603146 0.75 RAB9A (0.41) KMT2AMEN1NLRP3ALDH1A1HTT
SCHEMBL25014052 0.75 KMT2A (0.42) KMT2AMEN1ALDH1A1CYP1A2CYP2C9
SCHEMBL29216430 0.75 NOTUM (0.52) KMT2AMEN1ALDH1A1HTTHPGD
SCHEMBL16284295 0.73 HTR2A (0.44) KMT2AMEN1ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113896744-B Selective EGFR inhibitor 成都先导药物开发股份有限公司 2024-04-16 CN disclosed
CN-117794914-A Pyrimidine-2, 4-diamine derivatives, process for preparing the same, and pharmaceutical composition for preventing or treating cancer comprising the same as active ingredient 韩国化学研究院 2024-03-29 CN disclosed